Fenofibrate in Patients With Cervical Intraepithelial Neoplasia and Invasive Cervical Carcinoma — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(1 site)
United States
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio Last updated October 2025